TD Private Client Wealth LLC Buys 4,943 Shares of CME Group Inc. $CME

TD Private Client Wealth LLC increased its stake in shares of CME Group Inc. (NASDAQ:CME) by 118.3% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 9,123 shares of the financial services provider’s stock after buying an additional 4,943 shares during the quarter. TD Private Client Wealth LLC’s holdings in CME Group were worth $2,465,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of CME Group during the 2nd quarter worth approximately $1,571,447,000. Viking Global Investors LP purchased a new position in CME Group in the second quarter valued at approximately $164,648,000. Vanguard Group Inc. grew its holdings in CME Group by 1.5% during the second quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock valued at $9,695,313,000 after purchasing an additional 532,549 shares during the period. Magellan Asset Management Ltd increased its position in CME Group by 131,625.5% in the second quarter. Magellan Asset Management Ltd now owns 486,067 shares of the financial services provider’s stock worth $133,970,000 after buying an additional 485,698 shares during the last quarter. Finally, HRT Financial LP purchased a new stake in CME Group in the second quarter worth $127,103,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CME has been the topic of a number of recent research reports. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and upped their price target for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Keefe, Bruyette & Woods boosted their price objective on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. Piper Sandler upped their price objective on shares of CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Raymond James Financial lifted their target price on shares of CME Group from $307.00 to $311.00 and gave the stock an “outperform” rating in a research note on Monday, January 5th. Finally, TD Cowen boosted their price target on shares of CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a research report on Thursday, October 23rd. Nine investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $291.06.

CME Group Stock Up 1.3%

Shares of NASDAQ CME opened at $268.45 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market cap of $96.80 billion, a P/E ratio of 26.01, a P/E/G ratio of 3.42 and a beta of 0.27. CME Group Inc. has a 52 week low of $225.46 and a 52 week high of $290.79. The business has a 50-day simple moving average of $273.98 and a two-hundred day simple moving average of $271.78.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the prior year, the firm posted $2.68 earnings per share. The company’s revenue for the quarter was down 3.0% on a year-over-year basis. Research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were paid a $1.25 dividend. The ex-dividend date was Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is currently 48.45%.

Insider Buying and Selling at CME Group

In related news, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the sale, the director owned 1,091 shares in the company, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director William R. Shepard acquired 251 shares of the company’s stock in a transaction that occurred on Tuesday, December 30th. The shares were acquired at an average cost of $278.37 per share, with a total value of $69,870.87. Following the purchase, the director directly owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This trade represents a 0.10% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.